Hanson & Doremus Investment Management’s Cambria Cannabis ETF TOKE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-100
Closed -$1K 482
2024
Q1
$1K Hold
100
﹤0.01% 466
2023
Q4
$1K Hold
100
﹤0.01% 462
2023
Q3
$1K Hold
100
﹤0.01% 419
2023
Q2
$1K Hold
100
﹤0.01% 441
2023
Q1
$1K Hold
100
﹤0.01% 454
2022
Q4
$1K Hold
100
﹤0.01% 515
2022
Q3
$1K Hold
100
﹤0.01% 512
2022
Q2
$1K Hold
100
﹤0.01% 525
2022
Q1
$1K Hold
100
﹤0.01% 507
2021
Q4
$1K Hold
100
﹤0.01% 492
2021
Q3
$1K Buy
+100
New +$1.57K ﹤0.01% 484

Other funds holding TOKE

Hanson & Doremus Investment Management's TOKE Position: Q2 2024 in Review

Hanson & Doremus Investment Management sold out of Cambria Cannabis ETF (TOKE) in Q2 2024, closing a stake of 100 shares — an estimated $1K sold.

Hanson & Doremus Investment Management first reported a position in TOKE in Q3 2021 and held it in 11 quarters. The position peaked at $1K in Q1 2024. 16 funds tracked by Wall St. Rank hold TOKE as of Q2 2024.

  • Hanson & Doremus Investment Management reported no remaining Cambria Cannabis ETF position as of Q2 2024 after selling out during the quarter.
  • Hanson & Doremus Investment Management sold 100 Cambria Cannabis ETF shares in Q2 2024, an estimated $1K.
  • Hanson & Doremus Investment Management first reported a position in Cambria Cannabis ETF in Q3 2021 and held it in 11 quarters.
  • Hanson & Doremus Investment Management's Cambria Cannabis ETF position peaked at $1K in Q1 2024.
  • 16 funds tracked by Wall St. Rank held Cambria Cannabis ETF as of Q2 2024.

Based on Hanson & Doremus Investment Management's 13F filing for Q2 2024, filed 8 Aug 2024.